Sequence Similarity Clusters for the Entities in PDB 5I8C

Entity #1 | Chains: A
VRC34.01 Fab heavy chain protein, length: 223 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 5 5327
95 % 1 5 6213 Flexibility: Low
Max RMSD: 1.0, Avg RMSD: 0.6
PDBFlex
90 % 1 5 6169
70 % 44 2928 1
50 % 51 3079 1
40 % 51 3079 1
30 % 97 6153 1
Entity #2 | Chains: B
VRC34.01 Fab light chain protein, length: 212 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 5 5479
95 % 1 5 6212 Flexibility: Low
Max RMSD: 1.6, Avg RMSD: 0.8
PDBFlex
90 % 5 538 4
70 % 35 2391 2
50 % 44 3030 2
40 % 44 3030 2
30 % 98 6153 1
Entity #3 | Chains: C
HIV-1 Clade A BG505 Fusion Peptide (residue 512-520) protein, length: 9 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4NZU 1 L 13PL heavy chain Fab 9606
2 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
3 6MEE 2 B, D antibody HEPC74 Light Chain 9606
4 5UCB 2 L Fab Light Chain 9606
5 5I8C 2 B VRC34.01 Fab light chain 9606
6 5WK2 1 L M116 LIGHT CHAIN 9606
7 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
8 5VSI 2 L CH1/Ckappa Fab light chain 9606
9 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
10 4NWU 2 L APE1551 Ab Fab light chain 9606
11 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
12 5OB5 3 L fAb Light chain 9606
13 3QQ9 1 C, L 101F LIGHT CHAIN 10090
14 5UEA 3 B, L Fab Light Chain 9606
15 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
16 3QRG 1 L Fab light chain 9606
17 3NCJ 1 L Fab15 Mut8 light chain 9606
18 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
19 4NWT 1 L APE1531 Ab Fab light chain 9606
20 3NA9 1 L Fab15 light chain 9606
21 5U6A 1 A Light Chain 9606
22 5UEK 3 L Fab 12E Light Chain 9606
23 3NAA 1 L Fab15 Mut5 light chain 9606
24 5IK3 2 B, D 1E03 Fab fragment light chain 9606
25 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
26 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
27 5IT2 2 L light chain 9606
28 6MY4 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
29 6DW2 1 A 6078 Fab light chain 9606
30 6BQB 1 L MGG4 Fab light chain 9606
31 4PUB 2 L DX-2930 LIGHT CHAIN 9606
32 6B14 2 L Light chain of Fab BL3-6S97N 10090
33 5VKD 3 L Fab light chain 9606
34 5XHG 1 A, C polypeptide(L) 10090
35 3OAZ 2 K, L Fab 2G12, light chain 9606
36 6OTC 3 L sFab H3 light chain 32630
37 6MY5 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
38 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
39 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
40 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
41 4JHA 2 L D25 light chain 9606
42 6B9Z 1 A Trastuzumab Fab light chain 10090
43 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
44 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
45 6PE7 2 L FAB Light chain 9606
46 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
47 6IAS 2 L Fab NKp46-1 light chain 32630
48 6OBZ 2 B, L Light chain of FluA-20 Fab, Immunoglobulin light chain 9606
49 3P0Y 3 L Fab DL11 light chain 9606
50 6ANA 3 L LL2 Fab Light Chain 10090
51 6AOD 1 A FXIa Antibody FAB Light Chain 9606
52 6ELE 2 B, L fAB light chain 9606
53 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
54 3NAC 1 L Fab15 Mut7 light chain 9606
55 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
56 3EO9 1 L Efalizumab Fab fragment, light chain 9606
57 6N35 1 K, L Fab 2G12 light chain 9606
58 5WUV 1 L light chain 9606
59 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
60 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
61 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
62 6D0X 2 B 1210 Antibody, light chain 9606
63 1L7I 1 L chimera of Fab2C4: "humanized" murine monoclonal antibody The chimera consists of the human Ig and the original murine sequence light chain (residues 1-214) 9606
64 1JPT 1 L immunoglobulin Fab D3h44, light chain Fab fragment 9606
65 6O39 1 A Antibody F2.I Fab, Light chain 9606
66 5XKU 2 B HNIgGA6 light chain 9606
67 6MTT 1 L Antibody VRC46.01 Fb light chain 9606
68 5I18 1 L FAB LIGHT CHAIN 9606
69 3SOB 1 L antibody light chain 9606
70 6B5M 2 L CIS43 Fab Light chain 9606
71 4G6M 3 L light chain of gevokizumab antibody binding fragment 10090
72 4KQ3 1 L CNTO3186 light chain Fab 9606
73 2VXQ 3 L FAB L CHAIN OF THE FAB FRAGMENT COMPOSED OF THE IGE VARIABLE DOMAIN AND IGG CONSTANT DOMAIN 9606
74 4I77 2 L Lebrikizumab light chain Fab 9606
75 5WK3 1 P, R, T, V M116 LIGHT CHAIN 9606
76 4HJG 1 A Trastuzumab light chain 9606
77 3HC0 2 B, L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
78 5NYX 2 L, N, P LIGHT CHAIN fab light chain 9606
79 5IFA 2 L VRC01c-HuGL2 Fab light chain 9606
80 6ELJ 2 B, L fAB light chain 9606
81 4G6K 2 L light chain of gevokizumab antibody binding fragment 10090
82 1JPS 1 L immunoglobulin Fab D3H44, light chain Fab fragment 9606
83 6CBV 2 L Light Chain, Fab fragment 9606
84 5JW5 2 B, L MEDI8852 Light chain 9606
85 6DCV 1 A, L Light chain of CBTAU27.1 Fab 9606
86 3QWO 1 B, L motavizumab light chain 10090
87 4IOI 1 A Trastuzumab light chain 9606
88 5K8A 1 A, E, L, M humanized Fab Lite chain 10090
89 5VAG 2 B Light chain of antibody m826 9606
90 4RBP 1 K, L Fab 2G12 light chain 9606
91 6DCW 1 L Light chain of CBTAU27.1 Fab 9606
92 6B5N 2 L CIS43 Fab Light chain 9606
93 3OAY 1 K, L Fab 2G12, light chain 9606
94 6AND 3 L Pinatuzumab Fab light chain 9606
95 5JRP 1 L marberg virus monoclonal antibody MR78 Fab light chain 9606
96 5F7E 2 L Fab light chain 9606
97 1T3F 1 A Huzaf antibody light chain The source is engineered human constant and framework regions with CDRs from mouse 9606
98 5FHA 2 L Antibody 114 Fab light chain 9606
99 5UMN 3 D, F Antibody C05, light chain 9606
100 4X7S 2 L Ig kappa chain C region residues 23-236 9606
101 1S3K 1 L HU3S193 Fab fragment, light chain murine complementarity determining regions grafted onto human framework and constant sequences 10090
102 3QPQ 1 C, E, I, L C1068 light chain 10090
103 6PHB 2 A, C 2530 Antibody Fab, Light Chain 9606
104 6MXR 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
105 6ELL 2 B, L fAB light chain 9606
106 2HFF 1 A, L CB2 Fab, light chain 9606
107 4M7K 1 L 10H10 light chain SEE REMARK 999 10090
108 1VGE 1 L TR1.9 FAB FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY 9606
109 6MXS 2 B, L anti-VEGF-A Fab fragment bH1 light chain 9606
110 5I1L 1 A, L FAB LIGHT CHAIN 9606
111 5GGV 1 L light chain 9606
112 3L5X 1 L H2L6 LIGHT CHAIN 9606
113 5BJZ 3 H, L Synthetic antibody, Fab fragment, Light Chain 9606
114 2R8S 2 L Fab light chain 10090
115 4HKZ 1 A Trastuzumab light chain 9606
116 6DB8 3 L Fab-Light chain 32630
117 6DDR 1 A Anti-MICA Fab fragment light chain clone 13A9 10090
118 6MEH 3 L antibody HEPC74 Light Chain 9606
119 3OAU 2 L Fab 2G12, light chain 9606
120 5WEQ 1 A MR78 mutant light chain 9606
121 4ZYK 2 B, L AM14 light chain 9606
122 6DWA 1 A, L 4497 Fab Light Chain 9606
123 5E94 1 A, C Antibody Fab fragment light chain 10090
124 6MED 2 B, D, I antibody HEPC3 Light Chain 9606
125 1CE1 1 L PROTEIN (CAMPATH-1H:LIGHT CHAIN) FAB 9606
126 6ME1 2 B, D VRC34.01 Fab light chain 9606
127 5ITB 2 L anti-RSV F Fab 14N4 Light chain 9606
128 4KMT 1 L light chain O12/KAPPA Fab 9606
129 6CW3 2 B, D antibody light chain 9606
130 6BTJ 2 B, L Light chain of H7.5 Fab 9606
131 6BLI 2 B, E, H, K CB002.5 Fab Light Chain 9606
132 4XTR 3 D, F Antibody Light chain 32630
133 1RZ7 1 L Fab 48d light chain 9606
134 1RZG 2 B, D Fab 412d heavy chain 9606
135 5EA0 2 L Light chain of antibody 7968 Fab fragment 9606
136 3PGF 3 L SAB Light Chain 9606
137 6B9Y 1 A Trastuzumab Fab light chain 9606
138 2QQN 3 L Antibody light chain 9606
139 6MSY 1 L Fab 2G12, light chain 9606
140 3L5W 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
141 6BAE 1 A Trastuzumab Fab light chain 10090
142 4OGY 3 L, N DX-2930 LIGHT CHAIN 9606
143 2CMR 3 L D5 9606
144 5ZV3 3 L Light chain (kappa) of antibody CBTAU28.1 9606
145 4R4B 1 A, C, E, L FAB 2.2C LIGHT CHAIN 9606
146 5CZX 3 D, L 20358 Fab light chain 9606
147 6BI0 2 L, M Trastuzumab anti-HER2 Fab Light Chain 9606
148 3GRW 2 L Fab light chain 9606
149 6B3K 2 L Light chain of Fab BL3-6 10090
150 5I1D 1 A, L FAB LIGHT CHAIN 9606
151 5VKK 2 B, L Epratuzumab Fab Light Chain 10090
152 6AYZ 2 C, D Fab Light Chain 9606
153 6O3A 1 A Antibody F7.B Fab, Light chain 9606
154 1UJ3 1 A IgG Fab light chain anti-tissue-factor antibody hATR-5 Fab 9606
155 4LKC 1 A Fab fragment of PCSK9 antibody 9606
156 4KZD 2 L BL3-6 Fab antibody, light chain 10090
157 4CNI 2 B, L OLOKIZUMAB LIGHT CHAIN, FAB PORTION FAB PORTION 9606
158 6O1F 4 L Light Chain hu31A.v11 9606
159 4XH2 2 B, D, F, I, K, L Fab Light Chain 9606
160 5IES 2 L VRC01cHuGL2 Fab light chain 9606
161 6OCB 2 L Light chain of FluA-20 Fab 9606
162 6RCS 2 B R5.016 light chain 9606
163 3S34 1 L 1121B Fab light chain 10090
164 6B6Z 1 A, C Apo Fab Light Chain 9606
165 6EMJ 2 B, L fAb light chain 9606
166 5W1G 2 L CR1-07 Fab light chain 9606
167 6CNR 1 L Aducanumab light chain 9606
168 6OKM 2 L Fab 3C8 light chain 9606
169 3PNW 1 A, D, G, J, M, P, S, V FAB light chain 32630
170 4NRX 3 B, E, L m66 Light Chain 9606
171 3O2D 1 L ibalizumab light chain 10090
172 6DB9 3 L Fab-Light-Chain 32630
173 3HI6 3 L, Y light chain of Fab fragment of AL-57 against alpha L I domain 9606
174 5O14 3 D, L Fab 1A12 Light Chain 9606
175 4ZFG 3 L Fragment antigen binding 5A12 light chain 9606
176 6B5O 2 L CIS43 Fab Light chain 9606
177 2R0L 1 L antibody light chain 32630
178 5BK1 2 D, L Synthetic antibody, Fab fragment, Light Chain 9606
179 6N32 1 L, M Fab 2G12 light chain 9606
180 6TYB 4 L NEUTRALIZING ANTIBODY ITS90.03 FAB LIGHT CHAIN 9544
181 6DWC 1 A, L 4497 Fab Light Chain 9606
182 5VR9 2 B, L CH1/Ckappa Fab light chain 9606
183 5VZ1 1 A, C Apo Antibody Fab Light Chain 9606
184 5OD8 2 B B2 Fab fragment - Light chain 9606
185 3KR3 3 L antibody-Fab (light chain) 9606
186 6DZN 1 L Antibody ADI-15878, light chain 9606
187 5GGU 2 B, L light chain 9606
188 5KW9 3 L IgA Light chain 9606
189 5W2B 2 L Fab Light Chain 9606
190 6E4X 2 Y S5V2-29 light chain 9606
191 3C08 1 L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
192 6AXL 1 B, C Fab317 light chains 9606
193 6HIG 2 L Light Chain 10090
194 6CXG 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
195 6CO3 1 L Fab light chain 9606
196 4NRZ 2 B, L M66.6 LIGHT CHAIN Fab Light Chain 9606
197 3BN9 2 C, E E2 Fab Light Chain 9606
198 6DZR 2 L h38c2 light chain 9606
199 6DF0 1 L 4G10-4D5 Antibody Light chain 32630
200 6DF1 1 L Anti-phosphotyrosine antibody 4G10-4D5 heavy chain 9606
201 3L95 1 A, L anti-NRR1 fab fragment light chain 9606
202 4OGX 3 L DX-2930 LIGHT CHAIN 9606
203 4KZE 2 L BL3-6 Fab antibody, light chain 10090
204 6MU3 1 K, L Fab 2G12, light chain 9606
205 4XVU 3 D, F, J, L Antibody light chain 32630
206 5B71 1 A, C SKY59 Fab light chain 9606
207 6BF4 3 C, L VRC-PG05 Fab light chain 9606
208 3NAB 1 L Fab15 Mut6 light chain 9606
209 4Q9Q 2 L Fab BL3-6, LIGHT CHAIN 10090
210 4WV1 3 A, D Fab light chain 9606
211 5EII 2 B, L Fab Light Chain 9606
212 4FNL 2 L, M Antibody C05, Light Chain 9606
213 4UB0 2 L IgG1, light chain 9606
214 1FVD 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
215 1BJ1 1 J, L Fab fragment, light chain HUMANIZED VERSION OF A MONOCLONAL MURINE ANTI-VEGF ANTIBODY 10090
216 6BFT 1 B, L Avastin Light Chain Fab fragment mutant 9606
217 3IDX 3 L Fab b13 light chain 9606
218 5IF0 2 B, L VRC01c-HuGL2 Fab light chain 9606
219 4K94 1 L Fab19 heavy chain 9606
220 5K9Q 4 I, K, L, T, V, Y 16.a.26 Light chain 9606
221 6B5L 2 L CIS43 Fab Light Chain 9606
222 4ZD3 2 L 679-14-14E06 Fab fragment light chain 9606
223 5VEB 2 B, L anti-CDH6 Fab light chain 9606
224 6N81 2 D, L A1227 Fab light chain 9606
225 5E08 2 L Fab Light Chain 9606
226 6AZ2 3 E, F Fab Light Chain 9606
227 1CZ8 2 L, X LIGHT CHAIN OF NEUTRALIZING ANTIBODY MUTATED FORM OF A HUMANIZED MURINE ANTIBODY LIGHT CHAIN 10090
228 4XAK 3 E, L Light chain of neutralizing antibody m336 9606
229 5JQ6 3 L Tefibazumab FAB FRAGMENT LIGHT CHAIN 10090
230 6DF2 1 A, L Anti-phosphotyrosine antibody c310-4D5 heavy chain 32630
231 3HR5 1 A, L, P, Q Fab h47H4 light chain 10090
232 6AL4 1 A, C, E B43 LIGHT CHAIN 9606
233 4EDW 2 L tanezumab Fab light chain 9606
234 1FVE 1 A, C IGG1-KAPPA 4D5 FAB (LIGHT CHAIN) 9606
235 4NM4 1 L, M Antibody CR8043, Light Chain 9606
236 2H9G 1 A, L Fab BdF1, light chain Fab fragment 9606
237 4G7V 2 L fragment antibody light chain 9606
238 4HFW 1 A, L 6-26 Fab Light chain 9606
239 3L7E 1 A, L C836 LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
240 2XRA 3 L HK20, HUMAN MONOCLONAL ANTIBODY LIGHT CHAIN 9606
241 4LIQ 3 L Fab fragment RG7155 light chain Humanized Version of a monoclonal murine. 10090
242 5JO4 4 D G6 Fab Light Chain 9606
243 3INU 2 L, N KZ52 antibody fragment light chain 9606
244 5EU7 3 C, D FAB light chain 9606
245 1DFB 1 L IGG1-KAPPA 3D6 FAB (LIGHT CHAIN) 9606
246 1AD0 1 A, C ANTIBODY A5B7 (LIGHT CHAIN) FAB FRAGMENT 9606
247 4U6V 2 L, M Fab, antigen binding fragment, light chain 9606
248 2XA8 2 L OMALIZUMAB LIGHT CHAIN 9606
249 3EYV 1 A, L hu3S193 Fab, light chain 10090
250 6Q20 2 L 1E01 Fab kappa light chain 9606
251 5IJK 3 C, D 1E03 Fab fragment light chain 9606
252 3BDY 2 L Fab Fragment -Light Chain 9606
253 5I8E 2 B, D VRC34.01 Fab light chain 9606
254 3FZU 1 D, L immunoglobulin IgG1 Fab, light chain 9606
255 5UIX 2 L DH576 Fab light chain 9606
256 3K2U 4 L Antibody, Fab fragment, Light Chain 9606
257 5VSH 2 B, D, F, L CH1/Clambda Fab light chain 9606
258 1PG7 2 L, M humanized antibody D3H44 antigen-binding fragment 10090
259 2HFG 1 L CB3s Fab light chain (kappa) 9606
260 3GKW 2 L Light chain of the antibody Nimotuzumab 9606
261 3JWD 3 L, O FAB 48D LIGHT CHAIN 9606
262 5ZIA 2 B, E, I, L, M, P Light chain (kappa) of CBTAU-24.1 antibody 9606
263 4JQI 3 L Fab30 light chain 10090
264 6B0H 3 A, C 1262 antibody, light chain 9606
265 6U8C 2 C, L Antibody light chain Fab 9606
266 3SKJ 1 L, M Antibody, light chain 9606
267 3U30 2 B, E Light chain Fab 9606
268 6MFJ 2 B, L DH677.3 Fab light chain 9606
269 5HYS 2 B, D, F, L Uncharacterized protein 9606
270 3L7F 1 A, D, L H2L6 LIGHT CHAIN 9606
271 5I15 1 L FAB LIGHT CHAIN 9606
272 2FJF 1 A, C, E, G, J, L, M, O, Q, S, U, W Light Chain of a VEGF binding Antibody 9606
273 5I1E 1 L FAB LIGHT CHAIN 9606
274 4JLR 2 B, L Motavizumab Fab light chain 9606
275 2QQK 3 L Antibody Light Chain 9606
276 4J1U 1 A, C, E antibody 93F3 Light chain 10090
277 4RRP 1 A, B, C, D, E, F Fab antibody, light chain 9606
278 5SX5 1 K, L Panitumumab Fab Light Chain 9606
279 4XGZ 2 B, D, F, I, K, L, N, P, R, T, V, X FAB LIGHT CHAIN 9606
280 1N8Z 1 A Herceptin Fab (antibody) - light chain 10090
281 4OAW 1 A, C Light chain of Fab fragment of anti-HIV1 gp120 V2 mAb 2158 9606
282 5BK2 3 D, L sAB Light Chain 9606
283 1TZH 2 A, L Fab YADS1 Light Chain 10090
284 5O1R 3 L, M Uncharacterized protein 9606
285 4JZJ 3 B, L Fab Light Chain 10090
286 5BO1 3 L, M Fab light chain 9606
287 6FOE 2 B, L Fab BaxB01 light chain engineered Fab light chain binds oxidized macrophage migration inhibitory factor (MIF) 9606
288 4M6O 1 L CNTO7309 light chain 9606
289 5LSP 3 L, T 107_A07 Fab light chain 9606
290 6MWN 3 D, L Fab HAVx Light Chain 9606
291 4DVR 2 L Fab 48d Light chain 9606
292 6PI7 2 B, E Uncharacterized protein 9606
293 5BK3 1 B, D, F, L 580 Antibody, light chain 9606
294 6HXW 3 D, L IPH53 light chain 32630
295 4XWO 3 D, F, J, L, P, R, V, X Antibody light chain 32630
296 4ZFF 2 B, L Fragment antigen binding (Fab) 5A12 Light chain 9606
297 3HI5 2 L light chain of Fab fragment of AL-57 against alpha L I domain 9606
298 6BGT 2 A Herceptin light chain mutant 9606
299 5FUZ 2 L 645 FAB, LIGHT CHAIN 9606
300 3DVG 1 A Human IgG1 fab fragment light chain 9606
301 4HS8 3 L antibody hu5B3.v2 Fab light chain 9606
302 1B6D 1 A, B IMMUNOGLOBULIN IMMUNOGLOBULIN LIGHT-CHAIN DIMER 9606
303 3NFS 1 L Heavy chain of Fab fragment of daclizumab 9606
304 2FGW 1 L H52 FAB (LIGHT CHAIN) 9606
305 1B2W 1 L PROTEIN (ANTIBODY (LIGHT CHAIN)) V DOMAIN AND C DOMAIN 10090
306 2FJG 2 A, L Fab light chain 9606
307 4DKF 3 L, M FAb2 Light Chain 9606
308 5TLK 3 C, G H2191 LIGHT CHAIN 10090
309 6OGX 2 D Fab1 Light Chain 9606
310 6OGX 5 L Fab2 light chain 9606
311 1HEZ 1 A, C KAPPA LIGHT CHAIN OF IG 1-214 9606
312 6MEJ 5 L antibody HEPC3 Light Chain 9606
313 3EFD 1 L FabL 10090
314 4LF3 1 A, D Fab heavy chain 10090
315 6IAP 2 D Fab NKp46-4 light chain 32630
316 6IAP 5 L Fab NKp46-1 light chain 32630
317 5K59 4 F, L Fab light chain 9606
318 6MUB 1 K, L Fab 2G12, light chain 9606
319 6BFQ 2 B, D, F, L Fab Light Chain 9606
320 5KN5 2 B, E Epiregulin Antibody LY3016859 Fab Light Chain 9606
321 6O3B 1 A, E Antibody Fab F6, Light chain 9606
322 5F3H 2 B, D, F, H humanized RK35 antibody light chain 10090
323 4LEO 2 B RG7116 Fab light chain 10090
324 4G7Y 2 L Fragment antibody light chain 9606
325 4PY8 4 J antibody 3.1 light chain Fab 9606
326 3DVN 1 A, L Human IgG1 fab fragment light chain 9606
327 3IXT 1 B, L Motavizumab Fab light chain 10090
328 3UC0 3 L, M Light chain, monoclonal antibody 5H2 Fab 9598
329 1BBJ 1 A, L IGG4-KAPPA B72.3 FAB (LIGHT CHAIN) 10090
330 6U85 2 L antibody Fab Light chain 9606
331 5I1I 1 L FAB LIGHT CHAIN 9606
332 4NNP 3 L, Y Light chain of antagonistic fab fragment 9606
333 4ERS 1 L Fab light chain 9606
334 1DEE 1 A, C, E IGM RF 2A2 FAB LIGHT CHAIN 9606
335 2WUC 5 L FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
336 3SQO 3 L J16 Light chain 9606
337 4K3J 4 L Onartuzumab Fab light chain 10090
338 6PE8 2 B, L FAB Light chain 9606
339 6CYF 2 C, E, L, T IgG1 antibody, kappa light chain 9606
340 6MNF 1 K, L Fab 2G12, light chain 9606
341 4PY7 2 B, J antibody 3.1 light chain Fab 9606
342 6AL5 2 L B43 LIGHT CHAIN 9606
343 4K8R 3 C Fab1, light chain 9606
344 6HHC 1 L FXIA ANTIBODY FAB LIGHT CHAIN 9606
345 6ML8 4 L C05 antibody Fab light chain 9606
346 1TZI 1 A Fab YADS2 Light Chain 10090
347 4KUZ 1 L antibody 4A5 light chain Fab (mouse variable domain, human constant domain) 10090
348 4X7T 2 B, L Omalizumab-Fab Light chain 9606
349 4YK4 1 B, Y 641 I-9 VLCL antibody 9606
350 2QSC 1 L Fab F425-B4e8, Light chain Light chain 9606
351 1MHP 3 L, Y FAB FRAGMENT, light chain 10090
352 4N9G 2 B, F, L, N Antibody 17HD9, Light Chain 9544
353 6MEI 3 L antibody HEPC3 Light Chain 9606
354 3R1G 3 L FAB of YW412.8.31 antibody light chain 9606
355 2QQL 3 L Antibody Light Chain 9606
356 4MXV 2 E, L, X anti-Lymphotoxin alpha antibody light chain Fab 9606
357 5SX4 1 I, L Panitumumab Fab Light Chain 9606
358 3WD5 2 L Adalimumab Light Chain 9606
359 3EOA 1 A, L Efalizumab Fab fragment, light chain 9606
360 5GZO 3 D, L Antibody light chain 9606
361 2WUB 4 L, Q FAB FRAGMENT FAB40.DELTATRP LIGHT CHAIN 9606
362 4KY1 1 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN muHP1/2 CDRs + human kappa B3 germline VL framework 9606
363 4FP8 3 L, M, N, O Antibody C05, light chain 9606
364 6R2S 1 A Antibody DB9 light chain 9606
365 6I8S 3 I, J, K, L LIGHT CHAIN OF FAB FRAGMENT FROM AN PAI-1 ANTIBODY FAB FRAGMENT 9606
366 6CW2 4 B antibody light chain 9606
367 3BE1 3 L Fab Fragment-Light Chain 9606
368 2FJH 2 A, L Fab fragment light chain 9606
369 5XEZ 3 D, L Antibody, mAb1, light chain 9606
370 4K9E 1 L light chain 10090
371 3P0V 1 L, M Fab DL11 light chain 9606
372 2OQJ 1 A, D, G, J Fab 2G12 light chain 9606
373 6OEL 5 L engineered Fab light chain 9606
374 5VIG 2 B, L Fab light chain 9606
375 3HMX 3 L USTEKINUMAB FAB LIGHT CHAIN 9606
376 6I04 3 D, L Fab light chain 9606
377 5VYF 1 A, L Antibody light chain 10090
378 4K7P 1 X antibody rhumAb6 Fab fragment light chain Fab rhumAb6 9606
379 4K7P 4 L antibody 10C4 Fab fragment light chain 10090
380 5WUX 2 B, D, L light 9606
381 3OB0 1 K, L Fab 2G12, light chain Fab 9606
382 6MFP 4 D, L DH677.3 Fab light chain 9606
383 1T04 1 A, C Huzaf Antibody Light Chain The source is engineered human constant and framework regions with CDRs from mouse. 9606
384 6GK7 1 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-27.1(S31Y,T100I) FAB ANTIBODY FRAGMENT 9606
385 3ZTN 4 L FI6V3 ANTIBODY LIGHT CHAIN 9606
386 4I18 1 B, L antibody light chain Fab 10090
387 4Q9R 2 L Fab BL3-6, LIGHT CHAIN 10090
388 3IDY 3 C, L Fab b13 light chain 9606
389 3IVK 1 B, L Fab light chain man 10090
390 5I19 1 L FAB LIGHT CHAIN 9606
391 5TH9 1 L, M, N GS-5745 Fab light chain 9986
392 6OKN 2 B, D Fab 1A7 light chain 9606
393 6OC3 2 B, D Light chain of FluA-20 Fab 9606
394 6NZ7 4 I, L 429 B01 FAB light chain 9606
395 5X8L 2 K, L, M, N, O atezolizumab light chain 9606
396 5UDC 2 C, G, L MEDI8897 Fab Light Chain 9606
397 6GK8 2 L HUMAN FAB ANTIBODY FRAGMENT OF CBTAU-28.1(S32R;E35K) FAB ANTIBODY FRAGMENT 9606
398 5FEC 2 B, L germline 3BNC60 light chain 9606
399 1RZI 1 A, C, E, G, I, K, M, O Fab 47e light chain 9606
400 2R56 2 L, M IgE Fab Fragment, light chain 9606
401 1ZA6 1 A, C, E, G IGG Light chain 9606
402 4ZS6 1 D, L fab Light Chain 9606
403 4Z5R 2 A, J, L, P, R, T, V, Y anti-IFN-a antibody rontalizumab light chain 9606
404 6APB 3 L ADI-14359 Fab Light Chain 9606
405 5CD3 2 B, D, F, H DRVIA7 Light Chain 9606
406 6D01 2 B, D, F, H 1210 Antibody, Light chain 9606
407 6Q23 3 F, I, K, L 1G01 Fab kappa light chain 9606
408 5CZV 3 L Fab 20350 light chain 9606
409 5XF1 3 D, L Antibody mAb1 Light chain 9606
410 4P59 3 L MOR09825 Fab fragment light chain 9606
411 5XXY 2 L light chain of atezolizumab fab 9606
412 5CJO 3 L FAB light chain 10090
413 4LMQ 3 I, L Stromal cell-derived factor 1 9606
414 3N85 2 L Fab37 Light Chain 9606
415 3G6J 3 E, G Fab light chain 9606
416 5GJT 3 L light chain of human neutralizing antibody 3E1 light chain of neutralizing antibody 3E1 9606
417 6MH2 1 A, C Herceptin Fab arm light chain 9606
418 6K7O 3 C, E, G, L h128-3 Fab light chain 9606
419 3HMW 1 L USTEKINUMAB FAB LIGHT CHAIN 9606
420 5O4G 2 A MF3958 FAB light chain 9606
421 6PE9 2 B, D, F, L, M FAB Light chain 9606
422 2QAD 3 C, G anti-HIV-1 antibody 412d light chain FAB, ANTIGEN-BINDING FRAGMENT 9606
423 4DKE 3 L, M FAb1.1 Light Chain 9606
424 5VIC 2 L Fab light chain 9606
425 6MEK 3 D, L HEPC3 Light Chain 9606
426 3NFP 2 B, L Light chain of Fab fragment of daclizumab 9606
427 1BEY 1 L CAMPATH-1H ANTIBODY FAB FRAGMENT 9606
428 5GJS 3 L light chain of human neutralizing antibody 3E1 9606
429 6Q1Z 2 C, L 1G04 Fab kappa light chain 9606
430 4NRY 1 B, L m66 Heavy Chain 9606
431 6OE4 2 C, F CR9501 Fab Light Chain 9606
432 6N2X 1 K, L Fab 2G12 light chain 9606
433 3S37 1 L 1121B Fab light chain 10090
434 5XHF 1 A, C polypeptide (L chain) 10090
435 5VL7 4 L Fab33 light chain 9606
436 1PKQ 1 A, F (8-18C5) chimeric Fab, light chain 10090
437 6DEZ 1 A, L Anti-phosphotyrosine antibody PY20-4D5 light chain 32630
438 1S78 2 C, E Pertuzumab Fab light chain 10090
439 4NYL 1 B, D, F, L Adalimumab Light Chain 9606
440 5D1Z 1 A, H Y10 Light Chain 9606
441 5D1Z 3 C, E D4-10 Light Chain 9606
442 4XHJ 3 C, G Fab-RC light chain 9606
443 5O4O 1 A MF3178 FAB light chain 9606
444 5HJ3 4 B, F, J, N KZ52 Antibody Fragment 9606
445 5D1Q 1 A D2-06 Light Chain 9606
446 1ZA3 1 A, L Fab-YSd1 light chain Fab light chain 9606
447 3UAJ 3 D, L Light chain, monoclonal antibody 5H2 Fab 9598
448 3C09 1 B, L Matuzumab Fab Light chain Human/mouse chimeric derivative of mouse monoclonal antibody 425 10090
449 5XHV 3 L, Q S40 light chain 9606
450 4IOF 3 D, F Fab-bound IDE, light chain 10090
451 5FUO 3 L FAB LIGHT CHAIN 9606
452 4JHW 2 L D25 light chain 9606
453 4HG4 4 K, M, O, Q, S, U, W, Y, z Fab 2G1 light chain 9606
454 6CXL 1 K, L anti-HIV-1 Fab 2G12 light chain 9606
455 3ZTJ 4 H, J, L FI6V3 ANTIBODY LIGHT CHAIN 9606
456 4M1C 3 D, F Fab-bound IDE, light chain 9606
457 5UQY 3 C, G, K, O MR78 Fab light chain 9606
458 6D0U 3 D, F, I, L Antibody C05, light chain 9606
459 2JIX 1 A, G, L ABT-007 FAB FRAGMENT 9606
460 3ULV 2 L Fab15 light chain 9606
461 3ULV 6 E Fab1068 light chain 9606
462 4M7L 2 L 10H10 light chain SEE REMARK 999 10090
463 6OUS 4 N, P, R, T, V, X RB1 Fab Light chain 9606
464 4MXW 5 L, V anti-Lymphotoxin alpha antibody light chain Fab 9606
465 5UOE 3 L, N, Q, T, W FAB light chain 9606
466 5VL3 3 B, D, F, L Epratuzumab Fab Light Chain 10090
467 5JW3 4 L MEDI8852 light chain 9606
468 6D11 2 B, D 1450 Antibody, Light chain 9606
469 3S36 1 L 1121B light chain 10090
470 5CWS 1 A, G sAB-158 Fab Light Chain 9606
471 5I5K 3 L, Y Eculizumab light chain (variable domain) 9606
472 2R0K 2 L antibody light chain of Fab58 9606
473 3CSY 2 B, D, F, H Fab KZ52 light chain light chain 9606
474 5C8J 2 B, D, F, H Antibody fragment, light chain OBTAINED BY PHAGE DISPLAY FROM A LIBRARY OF HUMAN IGG. ANTIBODY FRAGMENT; THE CDRS ARE COMPLETELY SYNTHETIC 9606
475 4R4F 2 L Antibody 2.2c LIGHT CHAIN 9606
476 4G80 3 B, D, F, H fragment antibody light chain 9606
477 3JWO 3 L FAB 48D LIGHT CHAIN 9606
478 5CD5 3 D DRVIA7 Fab Light Chain 9606
479 3P11 2 L Fab DL11 light chain 9606
480 3ULU 2 L Fab15 light chain 9606
481 3ULU 6 E Fab1068 light chain 9606
482 5W1K 1 A, F, K, S CR1-28 Fab light chain 9606
483 4XI5 3 C Fab-94 light chain 9606
484 5WOB 4 J, L, N, P, R, T, V, X IDE-bound Fab light chain 60742
485 3EOB 1 A, L Efalizumab Fab fragment, light chain 9606
486 6EAY 1 L CA45 light chain 9541
487 5G64 3 L, M FAB FRAGMENT LIGHT CHAIN, RESIDUES 1-218 9606
488 4NM8 3 L, M, N Antibody CR8043, Light Chain 9606
489 5W1M 1 A, C, E, G CR1-07 Fab light chain 9606
490 6RCV 4 D, I R5.016 light chain 9606
491 5JW4 4 N, P, T, V, X MEDI8852 light chain 9606
492 5JW4 6 R MEDI8852 light chain 9606
493 2QR0 1 A, E, G, K, M, Q, S, W Fab-Fragment Light Chain 9606
494 5UDD 3 P, Q, R, S, T, U MEDI8897 Fab Light Chain 9606
495 5J3D 2 B, D, L 14N4 light chain 9606
496 4R4N 3 D, G, K, L, O, R, U, X Antibody 2.2c LIGHT CHAIN 9606
497 3EFF 1 A, C FAB 10090
498 3PJS 1 A, C FAB light chain 10090
499 6OE5 3 C Motavizumab Fab Light Chain 10090
500 6OE5 5 L CR9501 Fab Light Chain 9606
501 6MAM 2 B, D, F ADI-15946 Fab Light Chain 9606
502 5O7P 2 A MF3178 FAB light chain 9606
503 4ZYP 3 L, M, O Motavizumab antibody light chain 10090
504 4ZYP 5 E, G, I AM14 antibody light chain 9606
505 6RCU 4 D R5.016 light chain 9606
506 5DWU 4 L Fab - Light Chain 9606
507 5V2A 3 L Light chain (kappa) of H7.167 antibody Fab 9606
508 6EA7 4 L, N, R ADI-15878 Fab Light Chain 9606
509 5I8H 5 F, H VRC34.01 Fab light chain 9606
510 4FQR 4 b, d, f, h, j, l, n, p, r, t, v, x Broadly neutralizing antibody C05, light chain 9606
511 4R4H 3 L Antibody 2.2c, Light chain 9606
512 6EA5 4 L, N, R ADI-15878 Fab Light Chain 9606
513 5FHC 5 L Antibody 114 Fab light chain 9606
514 4XMN 6 L Antibody 87 light chain 32630
515 4XMM 8 L Antibody 57 light chain 9606
516 4NHH 1 F, G, K, L, P, Q 2G12 IgG dimer light chain 9606
517 4NHG 2 B, C, F, G, K, L 2G12 IgG dimer light chain 9606
518 6OT0 5 L Fab light chain 10090
519 6OGE 2 B Pertuzumab FAB LIGHT CHAIN 9606
520 6OGE 4 D Trastuzumab FAB LIGHT CHAIN 9606
521 6QD8 1 L, Y, Z Light chain 9606
522 6NC3 4 L, T, U, V, W, X Monoclonal antibody VRC34.01 fragment antigen binding light chain 9606
523 6MLM 4 G, I, L Light chain Fv of H7.5 Fab 9606
524 6MJZ 3 L PIA174 Fab Light chain 9606
525 6E5P 1 1, 4, K, L, Q, T 2G12 Light chain 9606
526 6E1K 2 C, E cat06 light chain 9606
527 6CMO 5 L Fab light chain 32630
528 6BF7 3 D, F Fab H11-E light chain 10090
529 6BF9 3 D, F Fab H11-E light chain 10090
530 6B7Z 3 D, F FAB H11 light chain 10090
531 6B70 3 D, F FAB H11-E light chain 10090
532 3J70 2 B, N, S monoclonal antibody 17b heavy chain 9606
533 3CM9 3 L, M, N, O Ig alpha-2 chain C region 9606
534 3CHN 1 L, M, N, O Immunoglobulin kappa light chain 9606
535 2QTJ 1 L, M, N, O Kappa light chain IgA1 9606
536 2ESG 1 L, M Immunoglobulin A1 light chain 9606
537 1R70 1 A, C Human IgA2(m1) Light Chain 9606
538 1IGA 2 C, D IGA1 CHAINS A AND B, HEAVY, CHAINS C AND D, LIGHT 9606